Long-term follow-up comparison of Durasphere and Contigen in the treatment of stress urinary incontinence

Journal of Lower Genital Tract Disease

Volumn 6, Issue 4, 2002, Pages 239-243

  Andersen, Roger C ^a  

^a NONE   (United States)

Author keywords

Contigen; Durasphere; Injectable bulking agent; Stress urinary incontinence

Indexed keywords

BULKING AGENT; DURASPHERE; GLUTARALDEHYDE CROSS LINKED COLLAGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEHAVIOR MODIFICATION; BLADDER SPHINCTER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPER; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DRUG SAFETY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HUMAN; INJECTION; INTRINSIC SPHINCTER DEFICIENCY; KINESIOTHERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MICTURITION; MUSCLE DISEASE; PELVIS FLOOR; RANDOMIZED CONTROLLED TRIAL; STRESS INCONTINENCE; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY TRACT SURGERY; URODYNAMICS;

EID: 0036773891     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200210000-00009     Document Type: Article

References (13)

1. Gorton E, Stanton S, Monga A. Periurethral collagen injection: a long-term follow-up study. Brit J Urol Intl 1999;84:966-71.
2. Aragona F, D'Urso L, Scremin E, Salmaso R, Passerini-Glazel G. Polytetrafluoroethylene giant granuloma and adenopathy: long-term complications following subureteral polytetrafluoroethylene injection for the treatment of vesicoureteral reflux in children. J Urol 1997;158:1539-42.
3. Kiilholma P, Chancellor M, Makinen J, Hirsch IH, Reenie PJ. Complications of Teflon injection for stress urinary incontience. Neurourol Urodyn 1993;12:131-7.
4. Appell RA. Collagen injection therapy for urinary incontinence. Urol Clin North Am 1994;21:177-82.
5. Herschorn S, Radomski SB. Collagen injections for genuine stress incontinence: patient selection and durability. Int Urogynecol J Pelvic Floor Dysfunct 1997;8:18-24.
6. Beavan A. Material properties and applications of Pyrolite® Carbon. Materials Engineering 1990;77:39-41.
7. Malizia AA Jr, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC, et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984;251:3277-81.
8. Stamey TA. Urinary incontinence in the female. In: Campbell's Urology. 4th ed. Philadelphia: WB Saunders Col; 1979:2272-93.
9. Groutz A, Blaivas JG, Kesler SS, Weiss JP, Chaikin DC. Outcome results of transurethral collagen injection for female stress urinary incontinence: assessment by urinary incontinence score. J Urol 2000;164:2006-9.
10. Bent AE, Foote J, Siegel S, Faerber G, Chaos R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 2001;166:1354-7.
11. Winters JC, Chiverton A, Scarpero HM, Prats LJ. Collagen injection therapy in elderly women: long-term results and patient satisfaction. Urology 2000;55:856-61.
12. Lightner D, Calvosa C, Andersen R, Klimber I, Brito CG, Snyder J, et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 2001;58:12-15.
13. Carbon Medical Technologies Company. PMAA Submission to the US Food and Drug Administration for IDE 980053, 1999. Rockville, MD: US Food and Drug Administration; 1999.